skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: MEDLINE Complete remover Nome da Publicação: Value In Health remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata
PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata
Material Type:
Artigo 		Adicionar ao Meu Espaço

PCR81 Patient-Centered Benefit-Risk Assessment of a Novel Therapy for Alopecia Areata

Mauer, J ; Whichello, C ; Hauber, B ; Krucien, N ; Law, E ; Trapali, M ; Senna, M ; Tervonen, T

Value in health, 2022-12, Vol.25 (12), p.S406-S406 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity
Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Study Of Costs Of The Cardiac And Diabetes Mellitus Patient In A Cardiology Hospital Of High Complexity

Costa, M.G.S.D ; Santos, M.S ; Tura, B.R ; Goulart, M.C ; Cintra, M.A.C.T ; Senna, K.M.S

Value in health, 2014-11, Vol.17 (7), p.A482-A482 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System
HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System
Material Type:
Artigo 		Adicionar ao Meu Espaço

HTA84 Cost-Utility Analysis of Talazoparib Versus Chemotherapy for Patients with Breast Cancer HER2- with Mutation in the BRCA1/2 Gene from the Brazilian Private Healthcare System

Almeida, P. ; Sebastião, M. ; Ferreira, P. ; Senna, T. ; Alexandre, R.F.

Value in health, 2023-06, Vol.26 (6), p.S274-S274 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective
EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE52 Cost-Effectiveness Analysis of Crizotinib Versus Chemoterapy for First Line Treatment of Non-Small Cell Lung Cancer Alk+, from the Brazilian Public Healthcare System Perspective

Ferreira, P. ; Senna, T. ; Sebastião, M. ; Alexandre, R.F. ; Almeida, P.

Value in health, 2023-06, Vol.26 (6), p.S68-S69 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective
EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE151 Cost-Minimization of Lorlatinib Versus Alectinib for First Line Treatment for Treatment of Alk-Positive Non–Small-Cell Lung Cancer from the Brazilian Private Healthcare System Perspective

Senna, T. ; Alexandre, R.F. ; Almeida, P. ; Sebastião, M. ; Ferreira, P.

Value in health, 2023-06, Vol.26 (6), p.S87-S87 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System
EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System

Alexandre, R.F. ; Almeida, P. ; Sebastião, M. ; Ferreira, P. ; Senna, T.

Value in health, 2023-06, Vol.26 (6), p.S77-S77 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective
EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

EE526 Cost-Effectiveness Analysis of Transthyretin-Associated Amyloid Cardiomyopathy from the Brazilian Public Healthcare System Perspective

Sebastião, M. ; Ferreira, P. ; Senna, T. ; Alexandre, R.F. ; Almeida, P.

Value in health, 2023-06, Vol.26 (6), p.S156-S156 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY
PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY
Material Type:
Artigo 		Adicionar ao Meu Espaço

PGI33 - URSODEOXYCHOLIC ACID TO GALLSTONE DISSOLUTION THERAPY IN ASYMPTOMATIC CHOLELITHIASIS PATIENTS: A SYSTEMATIC REVIEW OF THE EFFICACY AND SAFETY

Senna, K. ; Santos, M. ; Parreira, V.

Value in health, 2018-10, Vol.21, p.S146-S146 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
Material Type:
Artigo 		Adicionar ao Meu Espaço

PSY23 - AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE

Costa, M.G. ; Santos, M. ; Senna, K.

Value in health, 2018-10, Vol.21, p.S439-S440 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE
PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE
Material Type:
Artigo 		Adicionar ao Meu Espaço

PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS: A REVIEW OF THE LITERATURE

Biz, A.N. ; Santos, M. ; Senna, K.

Value in health, 2018-10, Vol.21, p.S246-S246 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2014  (1)
  2. 2014Até2015  (1)
  3. 2016Até2016  (2)
  4. 2017Até2018  (7)
  5. Após 2018  (9)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.